Lilly has been solidly investing in research and development (R&D) throughout 2024. In April, the company announced the ...

Eli Lilly has thrown its weight behind a cause beyond the traditional remit of pharma companies. | Eli Lilly has thrown its ...

Eli Lilly’s senior VP of information and R&D IT, Ramesh Durvasula, said Lilly will use AI and tech to transform the company.

Unfortunately, many of our elected leaders today undervalue the role of patents to progress the science of drug discovery and ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Hunsaker finds an improvement in the “volume and variety” of funding from the UKIB and others since his original report into ...

The case that Ozempic (NVO) and other GLP-1 medications could help people with substance use disorders is getting stronger.

Drugs such as Novo Nordisk’s Ozempic can cut drug and alcohol abuse by up to 50%, a study found, adding to mounting evidence ...

Britain will study whether the use of Eli Lilly’s weight loss drug can get people back into work and help tackle the high ...

The U.S. Food and Drug Administration (FDA) is rethinking its decision to remove popular weight-loss and diabetes drugs from ...

Artificial intelligence can revolutionize drug discovery by expediting development, reducing costs, and improving treatment ...

Lilly Ledbetter, a legendary advocate for women's equality and a driving force behind fair pay in America, died at 86 years ...